[Linagliptin - Re-assessment of benefit according to § 35a, Para. 5b, Social Code Book V (dossier assessment)]

Institut fuer Qualitaet und Wirtschaftlichkeit im Gesundheitswesen
Record ID 32018002920
German
Original Title: Linagliptin - Erneute Nutzenbewertung gemäß § 35a Absatz 5b SGB V
Details
Project Status: Completed
Year Published: 2012
English language abstract: There is no English language summary available
Publication Type: Full HTA
Country: Germany
MeSH Terms
  • Diabetes Mellitus, Type 2
  • Linagliptin
  • Dipeptidyl-Peptidase IV Inhibitors
  • Hypoglycemic Agents
Keywords
  • Linagliptin
  • Diabetes Mellitus ? Type 2
  • Benefit Assessment
Contact
Organisation Name: Institute for Quality and Efficiency in Health Care (IQWiG)
Contact Address: IQWiG, Im Mediapark, 8, DE-50670 Cologne, GERMANY, Tel: +49(0)221-35685, Fax: +49(0)221-356851
Contact Email: berichte@iqwig.de
Copyright: Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG)
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.